NCT02732249View on ClinicalTrials.gov

Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Given 30 min before morning and evening meals

DRUG

Bismuth Potassium Citrate

Given 30 min before morning and evening meals

DRUG

Clarithromycin

Given 30 min after morning and evening meals

DRUG

Metronidazole

Given 30 min after meals or at bedtime

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02732249 - Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment | Biotech Hunter | Biotech Hunter